1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BDCRC Early Career Investigator Grant is sponsored by Rare Diseases Clinical Research Network (RDCRN). The Early Career Investigator Grants (ECIG) address training needs in rare disease research by providing specialized education in the complexities of clinical research in the neuronal ceroid lipofuscinoses (NCLs).
While primarily focused on NCLs, the general aim of supporting early career investigators in rare disease research could potentially be relevant if the proposed research also contributes to the broader understanding of rare autoimmune conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Early career investigators conducting research in rare diseases, specifically in the neuronal ceroid lipofuscinoses (NCLs). Confirm the full requirements in the official notice before applying.
BDCRC Early Career Investigator Grant is funded by Rare Diseases Clinical Research Network (RDCRN). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleAt CGI on September 23, 2026, Global Impact Ventures committed $100 million over three years across economic opportunity, health, education, climate resilience and humanitarian needs. There is no application portal. The access route is the intermediary infrastructure — fiscal sponsorship, grantmaking administration, and a 250-organization network.
Read articleNOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read article